Basics PDS Biotechnology Corporation IPO Date: October 2, 2015 Sector: Healthcare Industry: Biotech Market Cap: $45.61M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.15% Avg Daily Range (30 D): $0.03 | 2.58% Avg Daily Range (90 D): $0.04 | 2.92% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .45M Avg Daily Volume (90 D): .42M Trade Size Avg Trade Size (Sh.): 178 Avg Trade Size (Sh.) (30 D): 310 Avg Trade Size (Sh.) (90 D): 257 Institutional Trades Total Inst.Trades: 26 Avg Inst. Trade: $1.98M Avg Inst. Trade (30 D): $1.59M Avg Inst. Trade (90 D): $1.16M Avg Inst. Trade Volume: .42M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.99M Avg Closing Trade (30 D): $.72M Avg Closing Trade (90 D): $.72M Avg Closing Volume: 791.96K     News Aug 13, 2025 @ 11:21 AM PDSB Loss Improves as Costs Drop Source: Jesterai Dec 6, 2024 @ 1:00 PM PDS Biotechnology Reports Inducement Grant Under N... Source: N/A Oct 2, 2024 @ 12:00 PM PDS Biotech Announces 36-Month Overall Survival Ra... Source: N/A Sep 9, 2024 @ 12:00 PM PDS Biotech to Present Updated VERSATILE-002 Data ... Source: N/A May 9, 2024 @ 9:46 PM PDS Biotech VERSATILE-002 Phase 2 Clinical Trial M... Source: PDS Biotechnology Corporation Financials   TTM Q4 2024 FY 2024 Basic EPS $-.21 $-.21 $-1.03 Diluted EPS $-.21 $-.21 $-1.03 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -8.49M $ -7.95M $ -37.61M Operating Income / Loss $ -9.11M $ -7.36M $ -36.32M Cost of Revenue $ $ $ Net Cash Flow $ M $ -8.06M $ -14.87M PE Ratio     Splits Mar 18, 2019:   1:20